Every open market buy and sale of Dianthus Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $75.1M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when DNTH insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an DNTH officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every DNTH insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Ryan SavitzEvp, CFO & Cbo | Sale plan | 124,042 | $90.52 | $11.2M | 0 | Nov 12Form 4 |
| Sep 17, 2026 | Edward CarrChief Accounting Officer | Sale plan | 20,000 | $101.38 | $2M | 0 | Sep 18Form 4 |
| Sep 1, 2026 | Simrat RandhawaEVP, Head of R&D | Sale plan | 23,124 | $106.41 | $2.5M | 4,000 | Sep 3Form 4 |
| Aug 19, 2026 | Simon ReadDirector | Sale plan | 2,778 | $117.55 | $327K | 0 | Aug 19Form 4 |
| Aug 10, 2026 | Simon ReadDirector | Sale plan | 2,777 | $109.55 | $304K | 0 | Aug 11Form 4 |
| Aug 10, 2026 | Adam M VenessSVP, General Counsel and Sec. | Sale plan | 20,000 | $110.44 | $2.2M | 0 | Aug 11Form 4 |
| Aug 10, 2026 | Anne McGeorgeDirector | Sale plan | 7,750 | $109.01 | $845K | 0 | Aug 11Form 4 |
| Aug 7, 2026 | Marino GarciaCEO And President | Sale plan | 166,000 | $108.11 | $17.9M | 65,292 | Aug 7Form 4 |
| Jul 9, 2026 | Ryan SavitzEvp, CFO & Cbo | Sale plan | 31,249 | $101.03 | $3.2M | 0 | Jul 13Form 4 |
| Jun 17, 2026 | Adam M VenessSVP, General Counsel and Sec. | Sale plan | 30,000 | $80.80 | $2.4M | 0 | Jun 18Form 4 |
| Jun 1, 2026 | Simrat RandhawaEVP, Head of R&D | Sale plan | 26,530 | $90.62 | $2.4M | 4,000 | Jun 2Form 4 |
| May 8, 2026 | Paula SoteropoulosDirector | Sale plan | 599 | $85.47 | $51K | 0 | May 11Form 4 |
| Apr 9, 2026 | Ryan SavitzEvp, CFO & Cbo | Sale plan | 8,224 | $89.84 | $739K | 0 | Apr 10Form 4 |
| Mar 31, 2026 | Paula SoteropoulosDirector | Sale plan | 599 | $80.11 | $48K | 0 | Apr 1Form 4 |
| Mar 31, 2026 | Ryan SavitzEvp, CFO & Cbo | Sale plan | 114,367 | $83.00 | $9.5M | 0 | Apr 1Form 4 |
DNTH insider trading FAQ
Are DNTH insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of DNTH on the open market in 0 trades, and 8 sold $75.1M in 20 trades, 100% of that under pre-arranged trading plans.
When did an DNTH insider last buy shares?
There has been no open market insider purchase of DNTH in the last two years.
When did an DNTH insider last sell shares?
Ryan Savitz (Evp, CFO & Cbo) sold 124,042 shares for $11.2M on Nov 12, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
